Is SWAV undervalued or overvalued?
As of 2025-03-22, the Intrinsic Value of Shockwave Medical Inc (SWAV) is 331.53 USD. This SWAV valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 334.75 USD, the upside of Shockwave Medical Inc is -1.00%. This means that SWAV is overvalued by 1.00%.
The range of the Intrinsic Value is 187.17 - 1,311.00 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 187.17 - 1,311.00 | 331.53 | -1.0% |
| DCF (Growth 10y) | 642.78 - 4,618.25 | 1,153.39 | 244.6% |
| DCF (EBITDA 5y) | 201.73 - 397.45 | 293.76 | -12.2% |
| DCF (EBITDA 10y) | 556.93 - 1,155.59 | 821.95 | 145.5% |
| Fair Value | 108.92 - 108.92 | 108.92 | -67.46% |
| P/E | 76.77 - 198.37 | 139.67 | -58.3% |
| EV/EBITDA | 32.81 - 123.17 | 72.04 | -78.5% |
| EPV | 10.06 - 21.95 | 16.01 | -95.2% |
| DDM - Stable | 48.19 - 399.39 | 223.79 | -33.1% |
| DDM - Multi | 258.78 - 1,728.37 | 456.04 | 36.2% |
| Market Cap (mil) | 12,566.51 |
| Beta | 0.57 |
| Outstanding shares (mil) | 37.54 |
| Enterprise Value (mil) | 13,017.65 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.66% |
| Cost of Debt | 4.69% |
| WACC | 7.48% |